Bio-Techne (TECH) Change in Accured Expenses (2009 - 2026)

Bio-Techne's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 214.0% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $13.1 million (up 171.72% YoY), while the FY2025 annual figure was $15.4 million, up 22.11% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $5.2 million, down from $14.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $27.6 million in Q1 2023, with the low at -$28.4 million in Q3 2022.
• The 5-year median for Change in Accured Expenses is $2.2 million (2022), against an average of $497058.8.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses slumped 1131.44% in 2022, then jumped 1136.26% in 2023.
• Bio-Techne's Change in Accured Expenses stood at -$4.9 million in 2022, then surged by 67.18% to -$1.6 million in 2023, then surged by 1018.82% to $14.8 million in 2024, then decreased by 5.4% to $14.0 million in 2025, then sank by 63.17% to $5.2 million in 2026.
• Business Quant data shows TECH's Change in Accured Expenses at $5.2 million in Q1 2026, $14.0 million in Q4 2025, and -$22.1 million in Q3 2025.